Chronic neutropenia: how best to assess severity and approach management?


Journal

Expert review of hematology
ISSN: 1747-4094
Titre abrégé: Expert Rev Hematol
Pays: England
ID NLM: 101485942

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 7 9 2021
medline: 3 3 2022
entrez: 6 9 2021
Statut: ppublish

Résumé

Neutropenia is a relatively common finding in medical practice and the medical approach requires a gradual and pertinent diagnostic procedure as well as adapted management. The area of chronic neutropenia remains fragmented between diverse diseases or situations. Here physicians involved in different aspects of chronic neutropenia gather both the data from medical literature till the end of May 2021 and their experience to offer a global approach for the diagnosis of chronic neutropenia as well as their medical care. In most cases, the neutropenia is transient, frequently related to a viral infection, and not harmful. However, neutropenia can be chronic (i.e. >3 months) and related to a number of etiologies, some clinically benign, such as so-called 'ethnic' neutropenia. Autoimmune neutropenia is the common form in young children, whereas idiopathic/immune neutropenia is a frequent etiology in young females. Inherited neutropenia (or congenital neutropenia) is exceptional, with approximately 30 new cases per 10

Identifiants

pubmed: 34486458
doi: 10.1080/17474086.2021.1976634
doi:

Substances chimiques

Granulocyte Colony-Stimulating Factor 143011-72-7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

945-960

Auteurs

Jean Donadieu (J)

Centre De Référence Des Neutropénies Chroniques, Registre National Des Neutropénies Congénitales, Service d'Hémato-oncologie Pédiatrique, Hôpital Armand Trousseau Aphp, Paris, France.

Stephanie Frenz (S)

Dr. Von Hauner Children's Hospital, Department of Pediatrics, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.

Lauren Merz (L)

Brigham and Women's Hospital, Department of Internal Medicine, Boston, MA, USA.

Flore Sicre De Fontbrune (F)

Service d'Hématologie Greffe, Hôpital St Louis APHP, Paris, France.

Gioacchino Andrea Rotulo (GA)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (Dinogmi), University of Genoa, Italy.

Blandine Beaupain (B)

Centre De Référence Des Neutropénies Chroniques, Registre National Des Neutropénies Congénitales, Service d'Hémato-oncologie Pédiatrique, Hôpital Armand Trousseau Aphp, Paris, France.

Martin Biosse-Duplan (M)

Service De Médecine Bucco-Dentaire, Hopital Bretonneau, Ap-hp, Paris, France.

Marie Audrain (M)

Service d'Immunologie Laboratoire De Biologie Chu De Nantes 9 Quai Moncousu.

Laure Croisille (L)

Laboratoire Hla-ilp E.f.s Ile -de-france 1, CRETEIL, France.

Phil Ancliff (P)

Pediatric Hematology, Great Ormond Street Hospital London, UK.

Christoph Klein (C)

Dr. Von Hauner Children's Hospital, Department of Pediatrics, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.

Christine Bellanné-Chantelot (C)

Département De Génétique Médicale, Sorbonne Université, Hôpital Pitié-Salpêtrière Aphp, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH